Pancreatitis crónica

  1. Iglesias-García, J.
  2. Lariño-Noia, J.
  3. Domínguez-Muñoz, J.E.
Revista:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Ano de publicación: 2020

Serie: 13

Número: 9

Páxinas: 477-487

Tipo: Artigo

DOI: HTTPS://DOI.ORG/10.1016/J.MED.2020.05.020 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Medicine: Programa de Formación Médica Continuada Acreditado

Resumo

Resumen La pancreatitis crónica es una enfermedad inflamatoria crónica del páncreas que se acompaña de fibrosis parenquimatosa y pérdida de tejido funcional, que en fases avanzadas lleva a desarrollar una insuficiencia pancreática exocrina y endocrina. Existen diferentes causas que en la actualidad se resumen en la clasificación TIGAR-O, siendo la más frecuente la tóxico-metabólica (alcohol y tabaco). Las manifestaciones clínicas más frecuentes son el dolor abdominal y los síntomas derivados de la insuficiencia pancreática exocrina. El diagnóstico de la pancreatitis crónica se basa en la detección de: a) alteraciones morfológicas, siendo las pruebas más importantes la ecoendoscopia y la colangiopancreatografía por resonancia magnética con secretina y la resonancia magnética con gadolinio y/o b) alteraciones funcionales, destacando la prueba de secretina. La insuficiencia pancreática exocrina se analiza mediante la prueba de elastasa fecal, asociada a un estudio nutricional completo o con métodos como la prueba del aliento con 13C-triglicéridos mixtos. El tratamiento de la enfermedad se centra en el tratamiento de la causa, en el control de los síntomas, principalmente el dolor, y en el manejo de sus complicaciones funcionales, como la insuficiencia pancreática exocrina y endocrina, o morfológicas, como el pseudoquiste, pseudoaneurisma o el cáncer de páncreas. Chronic pancreatitis is a chronic inflammatory disease of the pancreas that is accompanied by parenchymal fibrosis and loss of functional tissue, which in advanced phases leads to the onset of exocrine and endocrine pancreatic insufficiency. There are various causes that are currently summarised in the TIGAR-O classification, the most common of which is toxic-metabolic (alcohol and tobacco). The most common clinical manifestations are abdominal pain and symptoms resulting from exocrine pancreatic insufficiency. The diagnosis of chronic pancreatitis is based on detecting a) morphological abnormalities (with endoscopic ultrasonography and cholangiopancreatography by magnetic resonance imaging with secretin and magnetic resonance imaging with gadolinium) and/or b) functional abnormalities (with the secretin test). Exocrine pancreatic insufficiency is analysed through the faecal elastase test, combined with a complete nutritional study or with methods such as the 13C-mixed triglyceride breath test. Treatment for the disease is focused on treating the cause, controlling the symptoms (mainly pain) and managing its functional (e.g., exocrine and endocrine pancreatic insufficiency) and morphological complications (e.g., pseudocyst, pseudoaneurysm and pancreatic cancer).

Referencias bibliográficas

  • Chari ST. Defining chronic pancreatitis. Pancreatology. 2016; 16(5):694-5.
  • Löhr JM, Domínguez-Muñoz E, Rosendahl J, Besselink M, Ma-yerle J, Lerch MM, et al. United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterol J. 2017; 5(2):153-99.
  • Domínguez-Muñoz JE, Lucendo A, Carballo LF, Iglesias-García J, Tenías JM. A Spanish multicenter study to estimate the prevalence and incidence of chronic pancreatitis and its complications. Rev Esp Enferm Dig. 2014; 106(4):239-45.
  • Lévy P, Domínguez-Muñoz E, Imrie C, Löhr M, Maisonneuve P. Epide-miology of chronic pancreatitis: burden of the disease and consequences. United European Gastroenterol J. 2014;2(5):345-54.
  • Whitcomb DC, North American Pancreatitis Study Group. Pancreatitis: TIGAR-O Version 2 Risk/Etiology checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol. 2019; 10(6):e00027.
  • Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009; 169(11):1035-45.
  • Tolstrup JS, Kristiansen L, Becker U, Grønbaek M. Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study. Arch Intern Med. 2009;169(6):603-9.
  • Masson E, Chen J-M, Audrézet M-P, Cooper DN, Férec C. A conserva-tive assessment of the major genetic causes of idiopathic chronic pancrea-titis: data from a comprehensive analysis of PRSS1, SPINK1, CTRC and CFTR genes in 253 young French patients. PLoS ONE. 2013;8(8): e73522.
  • Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document. Pancreatology. 2010;10(6):664-72.
  • Drewes AM, Bouwense SAW, Campbell CM, Ceyhan GO, Del-haye M, Demir IE, et al. Guidelines for the understanding and ma-nagement of pain in chronic pancreatitis. Pancreatology. 2017;17(5): 720-31.
  • Lariño-Noia J, de la Iglesia D, Iglesias-García J, Macías F, Nieto L, Bas-tón I, et al. Morphological and functional changes of chronic pancreatitis in patients with dyspepsia: A prospective, observational, cross-sectional study. Pancreatology. 2018;18(3):280-5.
  • Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, et al. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol. 2010;8(5):433-8.
  • Domínguez-Muñoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diag-nosis and therapy of chronic pancreatitis. Pancreatology. 2018;18(8): 847-54.
  • Frøkjær JB, Akisik F, Farooq A, Akpinar B, Dasyam A, Drewes AM, et al. Guidelines for the diagnostic cross sectional imaging and severity scoring of chronic pancreatitis. Pancreatology. 2018;18(7): 764-73.
  • Iglesias-García J, Lariño-Noia J, Lindkvist B, Domínguez-Muñoz JE. Endoscopic ultrasound in the diagnosis of chronic pancreatitis. Rev Esp Enferm Dig. 2015;107(4):221-8.
  • Aabakken L, Rembacken B, LeMoine O, Kuznetsov K, Rey J-F, Rösch T, et al. Minimal standard terminology for gastrointestinal endoscopy - MST 3.0. Endoscopy. 2009;41(8):727-8.
  • Catalano MF, Sahai A, Levy M, Romagnuolo J, Wiersema M, Brugge W, et al. EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc. 2009;69(7):1251-61.
  • Iglesias-García J, Domínguez-Muñoz JE, Castiñeira-Alvariño M, Luaces-Regueira M, Lariño-Noia J. Quantitative elastography associated with endoscopic ultrasound for the diagnosis of chronic pancreatitis. Endosco-py. 2013;45(10):781-8.
  • Domínguez-Muñoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, et al. Recommendations from the United European Gastroenterology evidence-based guidelines for the diag-nosis and therapy of chronic pancreatitis. Pancreatology. 2018;18(8): 847-54.
  • Tirkes T, Fogel EL, Sherman S, Lin C, Swensson J, Akisik F, et al. Detec-tion of exocrine dysfunction by MRI in patients with early chronic pan-creatitis. Abdom Radiol (NY). 2017;42(2):544-51.
  • Balcı C. MRI assessment of chronic pancreatitis. Diagn Interv Radiol. 2011;17(3):249-54.
  • Domínguez Muñoz JE. Diagnosis of chronic pancreatitis: functional tes-ting. Best Pract Res Clin Gastroenterol. 2010;24(3):233-41.
  • Wu B, Conwell DL. The endoscopic pancreatic function test. Am J Gas-troenterol. 2009;104(10):2381-3.
  • Stevens T, Dumot JA, Parsi MA, Zuccaro G, Vargo JJ. Combined endos-copic ultrasound and secretin endoscopic pancreatic function test in pa-tients evaluated for chronic pancreatitis. Dig Dis Sci. 2010;55(9):2681-7.
  • Gardner TB, Purich ED, Gordon SR. Pancreatic duct compliance after secretin stimulation: a novel endoscopic ultrasound diagnostic tool for chronic pancreatitis. Pancreas. 2012;41(2):290-4.
  • Domínguez-Muñoz JE, Nieto L, Vilariño M, Lourido MV, Igle-sias-García J. Development and diagnostic accuracy of a breath test for pancreatic exocrine insufficiency in chronic pancreatitis. Pan-creas. 2016;45(2):241-7.
  • Domínguez-Muñoz JE, D Hardt P, Lerch MM, Löhr MJ. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig Dis Sci. 2017;62(5):1119-30.
  • Shalimar, Midha S, Hasan A, Dhingra R, Garg PK. Long-term pain relief with optimized medical treatment including antioxidants and step-up in-terventional therapy in patients with chronic pancreatitis. J Gastroenterol Hepatol. 2017;32(1):270-7.
  • Drewes AM, Kempeneers MA, Andersen DK, Arendt-Nielsen L, Besse-link MG, Boermeester MA, et al. Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons! Gut. 2019;68(8):1343-51.
  • Dumonceau J-M, Delhaye M, Tringali A, Arvanitakis M, Sánchez-Yague A, Vaysse T, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Updated August 2018. Endoscopy. 2019;51(2): 179-93.
  • Ahmed Ali U, Jens S, Busch ORC, Keus F, van Goor H, Gooszen HG, et al. Antioxidants for pain in chronic pancreatitis. Cochrane Database Syst Rev. 2014;(8):CD008945.
  • Gurusamy KS, Lusuku C, Davidson BR. Pregabalin for decreasing pan-creatic pain in chronic pancreatitis. Cochrane Database Syst Rev. 2016;2: CD011522.
  • Kemper M, Izbicki JR, Bachmann K. Surgical treatment of chronic pan-creatitis: the state of the art. Chirurgia (Bucur). 2018;113(3):300-6.
  • Wyse JM, Sahai AV. Endoscopic ultrasound-guided management of pain in chronic pancreatitis and pancreatic cancer: an update. Curr Treat Op-tions Gastroenterol. 2018;16(4):417-27.
  • Domínguez-Muñoz JE, Iglesias-García J. Oral pancreatic enzyme substi-tution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? JOP. 2010;11(2):158-62.
  • Lindkvist B, Phillips ME, Domínguez-Muñoz JE. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use. Pancreatolo-gy. 2015;15(6):589-97.
  • Domínguez-Muñoz JE, Álvarez-Castro A, Lariño-Noia J, Nieto L, Igle-sias-García J. Endoscopic ultrasonography of the pancreas as an indirect method to predict pancreatic exocrine insufficiency in patients with chro-nic pancreatitis. Pancreas. 2012;41(5):724-8.
  • Domínguez-Muñoz JE, Iglesias-García J, Castiñeira Alvariño M, Luaces Regueira M, Lariño-Noia J. EUS elastography to predict pancreatic exo-crine insufficiency in patients with chronic pancreatitis. Gastrointest En-dosc. 2015;81(1):136-42.
  • Domínguez-Muñoz JE. Management of pancreatic exocrine in-sufficiency. Curr Opin Gastroenterol. 2019;35(5):455-9.
  • Domínguez-Muñoz JE, Phillips M. Nutritional therapy in chronic pan-creatitis. Gastroenterol Clin North Am. 2018;47(1):95-106.
  • Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol. 2010;24(3):349-58.
Fonte de datos: Dialnet